ADAPY
Adaptimmune Therapeutics PLCCompany with tickers: ADAPY
CIK
1621227
Shares Outstanding
1,590,309,546
Website
https://www.adaptimmune.com
Investor Relations
https://www.adaptimmune.com/investors-and-media
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2025-10-20 | 2025-10-15 | |
| 8-K | 2025-09-26 | 2025-09-22 | |
| 8-K | 2025-09-12 | 2025-09-11 | |
| 8-K | 2025-09-08 | 2025-09-06 | |
| 8-K | 2025-08-29 | — | |
| 8-K | 2025-08-15 | — | |
| 8-K | 2025-08-14 | — | |
| 8-K | 2025-08-13 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-07-31 | — | |
| 8-K | 2025-07-28 | 2025-07-27 | |
| 8-K | 2025-07-17 | 2025-07-16 | |
| 8-K | 2025-05-29 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| 8-K | 2025-05-01 | — | |
| DEF 14A | 2025-04-25 | 2025-05-29 | |
| 8-K | 2025-04-14 | — | |
| 10-K | 2025-03-24 | 2024-12-31 | |
| 8-K | 2025-03-24 | — | |
| 8-K | 2025-03-20 | — | |
| 8-K | 2024-12-19 | 2024-12-18 | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-13 | — | |
| 8-K | 2024-11-01 | — | |
| 8-K | 2024-09-23 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-08-12 | — | |
| 8-K | 2024-08-02 | 2024-08-01 | |
| 8-K | 2024-07-16 | — | |
| 8-K | 2024-06-11 | — | |
| 8-K | 2024-05-30 | — | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-05-15 | 2024-05-14 | |
| 8-K | 2024-05-15 | — | |
| 8-K | 2024-05-14 | — | |
| 8-K | 2024-04-12 | 2024-04-10 | |
| DEF 14A | 2024-04-11 | 2024-05-14 | |
| 8-K | 2024-03-06 | — | |
| 10-K | 2024-03-06 | 2023-12-31 | |
| 8-K | 2024-02-27 | 2024-02-26 | |
| 8-K | 2024-02-16 | — | |
| 8-K | 2024-01-31 | — | |
| 8-K | 2024-01-04 | — | |
| 8-K | 2023-12-06 | — | |
| 8-K | 2023-11-14 | — | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 8-K | 2023-11-08 | — | |
| 8-K | 2023-11-03 | 2023-11-01 |
Showing 1–50 of 129 filings